Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

1.

Expanding the use of administrative claims databases in conducting clinical real-world evidence studies in multiple sclerosis.

Capkun G, Lahoz R, Verdun E, Song X, Chen W, Korn JR, Dahlke F, Freitas R, Fraeman K, Simeone J, Johnson BH, Nordstrom B.

Curr Med Res Opin. 2015 May;31(5):1029-39. doi: 10.1185/03007995.2015.1014029. Epub 2015 Mar 4.

PMID:
25661016
2.

Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis.

Bergvall N, Petrilla AA, Karkare SU, Lahoz R, Agashivala N, Pradhan A, Capkun G, Makin C, McGuiness CB, Korn JR.

J Med Econ. 2014 Oct;17(10):696-707. doi: 10.3111/13696998.2014.940422. Epub 2014 Jul 23.

PMID:
25019581
3.

Estimating effectiveness and cost of biologics for rheumatoid arthritis: application of a validated algorithm to commercial insurance claims.

Curtis JR, Schabert VF, Harrison DJ, Yeaw J, Korn JR, Quach C, Yun H, Joseph GJ, Collier DH.

Clin Ther. 2014 Jul 1;36(7):996-1004. doi: 10.1016/j.clinthera.2014.05.062. Epub 2014 Jul 8.

PMID:
25012729
4.

Use of a validated algorithm to estimate the annual cost of effective biologic treatment for rheumatoid arthritis.

Curtis JR, Schabert VF, Yeaw J, Korn JR, Quach C, Harrison DJ, Yun H, Joseph GJ, Collier D.

J Med Econ. 2014 Aug;17(8):555-66. doi: 10.3111/13696998.2014.914031. Epub 2014 May 14.

PMID:
24754646
5.

Healthcare resource use and relapses with fingolimod versus natalizumab for treating multiple sclerosis: a retrospective US claims database analysis.

Bergvall N, Lahoz R, Reynolds T, Korn JR.

Curr Med Res Opin. 2014 Aug;30(8):1461-71. doi: 10.1185/03007995.2014.915802. Epub 2014 May 2.

PMID:
24754349
6.

Relapse rates in patients with multiple sclerosis switching from interferon to fingolimod or glatiramer acetate: a US claims database study.

Bergvall N, Makin C, Lahoz R, Agashivala N, Pradhan A, Capkun G, Petrilla AA, Karkare SU, McGuiness CB, Korn JR.

PLoS One. 2014 Feb 6;9(2):e88472. doi: 10.1371/journal.pone.0088472. eCollection 2014.

7.

Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis.

Bergvall N, Makin C, Lahoz R, Agashivala N, Pradhan A, Capkun G, Petrilla A, Karkare SU, Balderston McGuiness C, Korn JR.

Curr Med Res Opin. 2013 Dec;29(12):1647-56. doi: 10.1185/03007995.2013.847411. Epub 2013 Oct 1.

PMID:
24059944
8.

Incidence of venous thromboembolism among chemotherapy-treated patients with lung cancer and its association with mortality: a retrospective database study.

Huang H, Korn JR, Mallick R, Friedman M, Nichols C, Menzin J.

J Thromb Thrombolysis. 2012 Nov;34(4):446-56. doi: 10.1007/s11239-012-0741-7.

PMID:
22581282
9.

The relationship between use of antidepressants and resource utilization among patients with manic or mixed bipolar disorder episodes: findings from a managed care setting.

Sussman M, Friedman M, Korn JR, Hassan M, Kim J, Menzin J.

J Affect Disord. 2012 May;138(3):425-32. doi: 10.1016/j.jad.2011.12.048. Epub 2012 Feb 11.

PMID:
22326843
10.

Medical care costs and survival associated with hepatocellular carcinoma among the elderly.

White LA, Menzin J, Korn JR, Friedman M, Lang K, Ray S.

Clin Gastroenterol Hepatol. 2012 May;10(5):547-54. doi: 10.1016/j.cgh.2011.12.031. Epub 2011 Dec 29.

PMID:
22210536
11.

Medication adherence and hospitalization among patients with schizophrenia treated with antipsychotics.

Lang K, Meyers JL, Korn JR, Lee S, Sikirica M, Crivera C, Dirani R, Menzin J.

Psychiatr Serv. 2010 Dec;61(12):1239-47. doi: 10.1176/appi.ps.61.12.1239.

PMID:
21123409
12.

The economic costs to United States hospitals of invasive fungal infections in transplant patients.

Menzin J, Meyers JL, Friedman M, Korn JR, Perfect JR, Langston AA, Danna RP, Papadopoulos G.

Am J Infect Control. 2011 May;39(4):e15-20. doi: 10.1016/j.ajic.2010.06.009. Epub 2010 Oct 20.

PMID:
20961657
13.

Development of an interactive model of the burden of future coronary heart disease from an employer perspective.

Lang K, Korn JR, Simko RJ, Zachry WM, Patel NV, Nair R, Menzin J.

J Occup Environ Med. 2010 Sep;52(9):851-7. doi: 10.1097/JOM.0b013e3181ebbb3d.

PMID:
20798652
14.

Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.

Menzin J, Korn JR, Cohen J, Lobo F, Zhang B, Friedman M, Neumann PJ.

J Manag Care Pharm. 2010 May;16(4):264-75.

15.

Trends in healthcare utilization among older Americans with colorectal cancer: a retrospective database analysis.

Lang K, Lines LM, Lee DW, Korn JR, Earle CC, Menzin J.

BMC Health Serv Res. 2009 Dec 10;9:227. doi: 10.1186/1472-6963-9-227.

16.

Factors associated with improved survival among older colorectal cancer patients in the US: a population-based analysis.

Lang K, Korn JR, Lee DW, Lines LM, Earle CC, Menzin J.

BMC Cancer. 2009 Jul 13;9:227. doi: 10.1186/1471-2407-9-227.

17.

Neuromuscular blockade, reversal agent use, and operating room time: retrospective analysis of US inpatient surgeries.

Zhang B, Hepner DL, Tran MH, Friedman M, Korn JR, Menzin J.

Curr Med Res Opin. 2009 Apr;25(4):943-50. doi: 10.1185/03007990902769054 .

PMID:
19257799
18.

Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data.

Lang K, Lines LM, Lee DW, Korn JR, Earle CC, Menzin J.

Clin Gastroenterol Hepatol. 2009 Feb;7(2):198-204. doi: 10.1016/j.cgh.2008.08.034. Epub 2008 Sep 4.

PMID:
18849013
19.

Predicted coronary risk for adults with coronary heart disease and low HDL-C: an analysis from the US National Health and Nutrition Examination Survey.

Zhang B, Menzin J, Friedman M, Korn JR, Burge RT.

Curr Med Res Opin. 2008 Sep;24(9):2711-7. doi: 10.1185/03007990802363198 . Epub 2008 Aug 12.

PMID:
18701005
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk